DocGo (NASDAQ:DCGO) Rating Reiterated by Cantor Fitzgerald

DocGo (NASDAQ:DCGOGet Free Report)‘s stock had its “overweight” rating reaffirmed by stock analysts at Cantor Fitzgerald in a research report issued on Friday, Benzinga reports. They currently have a $5.00 price target on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 44.51% from the company’s current price.

Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $7.00 price target on shares of DocGo in a report on Thursday, August 8th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $6.10.

Get Our Latest Research Report on DCGO

DocGo Trading Down 3.9 %

Shares of DCGO traded down $0.14 during trading hours on Friday, hitting $3.46. The company had a trading volume of 628,269 shares, compared to its average volume of 1,104,831. The company has a market capitalization of $351.42 million, a PE ratio of 17.30, a price-to-earnings-growth ratio of 3.02 and a beta of 0.92. DocGo has a one year low of $2.75 and a one year high of $6.90. The company’s fifty day moving average price is $3.48 and its two-hundred day moving average price is $3.41.

DocGo (NASDAQ:DCGOGet Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). DocGo had a return on equity of 8.90% and a net margin of 3.97%. The firm had revenue of $164.95 million during the quarter, compared to the consensus estimate of $166.61 million. Analysts forecast that DocGo will post 0.23 earnings per share for the current year.

Institutional Investors Weigh In On DocGo

A number of large investors have recently made changes to their positions in DCGO. Harbor Capital Advisors Inc. raised its stake in DocGo by 273.4% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 396,015 shares of the company’s stock worth $1,224,000 after acquiring an additional 289,964 shares during the last quarter. Jacobs Levy Equity Management Inc. acquired a new stake in shares of DocGo during the first quarter worth about $672,000. Birchview Capital LP boosted its position in DocGo by 15.4% in the fourth quarter. Birchview Capital LP now owns 150,000 shares of the company’s stock valued at $838,000 after buying an additional 20,000 shares during the last quarter. S Squared Technology LLC increased its holdings in DocGo by 36.7% in the 4th quarter. S Squared Technology LLC now owns 1,024,438 shares of the company’s stock worth $5,727,000 after buying an additional 275,000 shares during the period. Finally, Pasadena Private Wealth LLC increased its holdings in DocGo by 363.6% in the 1st quarter. Pasadena Private Wealth LLC now owns 395,487 shares of the company’s stock worth $1,598,000 after buying an additional 310,180 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.

DocGo Company Profile

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Articles

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.